Selective butyrylcholinesterase inhibitors could be the promising drug candidates, used in treatment of Alzheimer's disease. The study describes the synthesis and biological activity of novel carbamate derivatives with N-phenylpiperazine, N-benzylpiperazine and 4-benzylpiperidine moieties. Biological studies revealed that most of these compounds displayed significant activity against BuChE. Compound 16 (3-(4-phenyl-piperazin-1-ylmethyl)-phenyl phenylcarbamate) turned out to be the most active (IC50=2.00muM for BuChE). For all synthesized compounds lipophilicity and other physicochemical properties were calculated using computer programs. Relationship between these properties and activity was also checked. Binding mode with enzyme and the ensuing differences in activity were explained by the molecular modeling studies.
        
Related information
Citations formats
Bajda M, Latka K, Hebda M, Jonczyk J, Malawska B (2018) Novel carbamate derivatives as selective butyrylcholinesterase inhibitors Bioorg Chem78: 29-38
Bajda M, Latka K, Hebda M, Jonczyk J, Malawska B (2018) Bioorg Chem78: 29-38